Literature DB >> 21796477

Age and obesity are risk factors for adverse events after total hip arthroplasty.

James I Huddleston1, Yun Wang, Carlos Uquillas, James H Herndon, William J Maloney.   

Abstract

BACKGROUND: Defining the epidemiology of adverse events after THA will aid in the development of strategies to enhance perioperative care. QUESTIONS/PURPOSES: We identified (1) risk factors for adverse events in Medicare beneficiaries while hospitalized after THA and (2) trends in the rates of adverse events. PATIENTS AND METHODS: Data were abstracted from medical records of 1809 Medicare beneficiaries who underwent THA from 2002 to 2007. We used the hierarchical generalized linear modeling approach to assess the odds of change in adverse events over time, the association of adverse events with outcomes, and the relationship of adverse events with patient characteristics by modeling the log-odds of adverse events as a function of demographic and clinical variables adjusted for year variable.
RESULTS: The overall rate of adverse events was 5.8%; the 30-day mortality rate was 1.00%. Increased age, obesity, and year of procedure were risk factors for experiencing any adverse event. Annual rates of adverse events from 2002 to 2007 were 9.1%, 8.2%, 4.9%, 4.1%, 3.5%, and 3.0%, respectively. Experiencing any adverse event was associated with an increased length of stay and an increased chance of readmission but not with an increased chance of mortality. The annual rate of all adverse events decreased from 2002-2004 to 2005-2007 (odds ratio = 0.83; 95% confidence interval, 0.74-0.92).
CONCLUSIONS: Older and obese patients should be counseled regarding their increased risk for the development of adverse events after THA. The cause of the decline in the rate of adverse events between two time periods is unclear and warrants further investigation to confirm and identify the cause.

Entities:  

Mesh:

Year:  2012        PMID: 21796477      PMCID: PMC3254770          DOI: 10.1007/s11999-011-1967-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

1.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.

Authors:  Steven Kurtz; Kevin Ong; Edmund Lau; Fionna Mowat; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2007-04       Impact factor: 5.284

2.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Authors:  R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe
Journal:  Arthritis Rheum       Date:  1998-05

3.  Racial/ethnic differences in surgical outcomes in veterans following knee or hip arthroplasty.

Authors:  Said A Ibrahim; Roslyn A Stone; Xiaoyan Han; Peter Cohen; Michael J Fine; William G Henderson; Shukri F Khuri; C Kent Kwoh
Journal:  Arthritis Rheum       Date:  2005-10

4.  The validity of using administrative claims data in total joint arthroplasty outcomes research.

Authors:  Kevin J Bozic; Vanessa W Chiu; Steven K Takemoto; Jordan N Greenbaum; Thomas M Smith; Seth A Jerabek; Daniel J Berry
Journal:  J Arthroplasty       Date:  2010-06-08       Impact factor: 4.757

5.  Patient perceptions of access to care and referrals to specialists: a comparison of African-American and white older patients with knee and hip osteoarthritis.

Authors:  John P F Lopez; Christopher J Burant; Laura A Siminoff; C Kent Kwoh; Said A Ibrahim
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

6.  Thirty-day mortality after elective total hip arthroplasty.

Authors:  J Parvizi; B G Johnson; C Rowland; M H Ereth; D G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2001-10       Impact factor: 5.284

7.  Rates and outcomes of primary and revision total hip replacement in the United States medicare population.

Authors:  Nizar N Mahomed; Jane A Barrett; Jeffrey N Katz; Charlotte B Phillips; Elena Losina; Robert A Lew; Edward Guadagnoli; William H Harris; Robert Poss; John A Baron
Journal:  J Bone Joint Surg Am       Date:  2003-01       Impact factor: 5.284

8.  A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip.

Authors:  R W Chang; J M Pellisier; G B Hazen
Journal:  JAMA       Date:  1996-03-20       Impact factor: 56.272

9.  Postoperative mortality after total hip arthroplasty. An analysis of deaths after two thousand seven hundred and thirty-six procedures.

Authors:  J T Dearborn; W H Harris
Journal:  J Bone Joint Surg Am       Date:  1998-09       Impact factor: 5.284

  9 in total
  29 in total

1.  Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?

Authors:  Elizabeth W Paxton; Maria C S Inacio; Jasvinder A Singh; Rebecca Love; Stefano A Bini; Robert S Namba
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

2.  Neither pre-operative education or a minimally invasive procedure have any influence on the recovery time after total hip replacement.

Authors:  David Jean Biau; Raphael Porcher; Alexandra Roren; Antoine Babinet; Nadia Rosencher; Sylvie Chevret; Serge Poiraudeau; Philippe Anract
Journal:  Int Orthop       Date:  2015-05-15       Impact factor: 3.075

Review 3.  [Tribology in hip arthroplasty : Benefits of different materials].

Authors:  J Philippe Kretzer; Maximilian Uhler; Sebastian Jäger; Therese Bormann; Robert Sonntag; Mareike Schonhoff; Stefan Schröder
Journal:  Orthopade       Date:  2021-02-25       Impact factor: 1.087

4.  Are Readmissions After THA Preventable?

Authors:  Douglas S Weinberg; Matthew J Kraay; Steven J Fitzgerald; Vasu Sidagam; Glenn D Wera
Journal:  Clin Orthop Relat Res       Date:  2016-11-11       Impact factor: 4.176

5.  A minimally invasive approach for total hip arthroplasty does not diminish early post-operative outcome in obese patients: a prospective, randomised trial.

Authors:  Thomas Dienstknecht; Christian Lüring; Markus Tingart; Joachim Grifka; Ernst Sendtner
Journal:  Int Orthop       Date:  2013-02-28       Impact factor: 3.075

Review 6.  The challenge of infection prevention in spine surgery: an update.

Authors:  T Ferry; F Valour; S Lustig; F Laurent; G Perrin; C Chidiac; C Barrey
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-05-21

7.  The economic impact of periprosthetic infection in total hip arthroplasty

Authors:  Jason Akindolire; Mina W. Morcos; Jacquelyn D. Marsh; James L. Howard; Brent A. Lanting; Edward M. Vasarhelyi
Journal:  Can J Surg       Date:  2020-01-29       Impact factor: 2.089

8.  Re-admissions treble the risk of late mortality after primary total hip arthroplasty.

Authors:  Pablo A Slullitel; Martín Estefan; Wilber M Ramírez-Serrudo; Fernando M Comba; Gerardo Zanotti; Francisco Piccaluga; Martín A Buttaro
Journal:  Int Orthop       Date:  2018-03-10       Impact factor: 3.075

Review 9.  New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty.

Authors:  Garrett B Aikens; Jacob R Osmundson; Michael P Rivey
Journal:  World J Orthop       Date:  2014-07-18

10.  Obesity increases length of stay and direct medical costs in total hip arthroplasty.

Authors:  Hilal Maradit Kremers; Sue L Visscher; Walter K Kremers; James M Naessens; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2013-10-08       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.